Bernhard Krieger

Title: Bernhard Krieger: Innovator in Pharmaceutical Chemistry

Introduction

Bernhard Krieger is a notable inventor based in Unna, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. His work has led to the filing of multiple patents, showcasing his innovative approach to drug development.

Latest Patents

Krieger holds 2 patents, with his latest inventions focusing on the production of specific steroid compounds. One of his patents details a process for the production of 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-4-pregnene-3,20-dione and its derivatives. This compound is significant for its potential therapeutic applications. Another patent involves the preparation of 4-Androsten-3-ones, which are known to exhibit diuretic activity. These innovations highlight Krieger's expertise in synthesizing complex organic molecules.

Career Highlights

Krieger is associated with Schering Aktiengesellschaft, a prominent pharmaceutical company. His role at Schering has allowed him to work on cutting-edge research and development projects. His contributions have been instrumental in advancing the company's portfolio of pharmaceutical products.

Collaborations

Throughout his career, Krieger has collaborated with esteemed colleagues, including Rainer Philippson and Jorge Casals-Stenzel. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Bernhard Krieger's work in pharmaceutical chemistry exemplifies the impact of innovative thinking in drug development. His patents and collaborations reflect a commitment to advancing medical science and improving therapeutic options.